Security key
462222100
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS)
CUSIP: 462222100
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 166,460,189
- Total 13F shares
- 130,693,455
- Share change
- +4,435,022
- Total reported value
- $4,936,957,475
- Put/Call ratio
- 65%
- Price per share
- $37.77
- Number of holders
- 333
- Value change
- +$160,016,480
- Number of buys
- 157
- Number of sells
- 153
Report period
Q4 2022
Institutions
333
Top holders
10
IONS full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
IONIS PHARMACEUTICALS INC SEC filings
IONIS PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 462222100
Recent filing periods:
Top shareholders of IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
13%
|
21,291,159
|
$941,708,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.7%
|
12,806,023
|
$566,411,000 | — | 30 Sep 2022 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
6.7%
|
11,156,695
|
$493,461,000 | — | 30 Sep 2022 | |
| Bellevue Group AG |
13F
|
Company |
5.7%
|
9,463,400
|
$418,566,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
8,936,062
|
$395,240,000 | — | 30 Sep 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3.5%
|
5,773,892
|
$255,379,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
4,797,132
|
$212,178,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
3,760,955
|
$166,347,000 | — | 30 Sep 2022 | |
| ARK Investment Management LLC |
13F
|
Company |
2.2%
|
3,713,107
|
$164,231,000 | — | 30 Sep 2022 | |
| BVF INC/IL |
13F
|
Company |
1.7%
|
2,872,953
|
$127,071,000 | — | 30 Sep 2022 | |
| Tweedy, Browne Co LLC |
13F
|
Company |
1.6%
|
2,722,988
|
$120,438,000 | — | 30 Sep 2022 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.2%
|
2,077,260
|
$91,877,000 | — | 30 Sep 2022 | |
| Camber Capital Management LP |
13F
|
Company |
1.2%
|
1,925,000
|
$85,143,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,901,143
|
$84,087,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.78%
|
1,290,565
|
$57,081,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
1,202,346
|
$53,181,000 | — | 30 Sep 2022 | |
| NORGES BANK |
13F
|
Company |
0.72%
|
1,190,751
|
$52,666,917 | — | 30 Sep 2022 | |
| Swedbank AB |
13F
|
Company |
0.61%
|
1,021,429
|
$45,177,805 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.56%
|
928,752
|
$41,079,000 | — | 30 Sep 2022 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.55%
|
908,479
|
$40,182,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
867,714
|
$38,379,000 | — | 30 Sep 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.5%
|
834,041
|
$36,965,000 | — | 30 Sep 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.48%
|
804,083
|
$35,605,000 | — | 30 Sep 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.46%
|
768,900
|
$34,008,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.42%
|
696,538
|
$30,809,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.41%
|
689,872
|
$30,513,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.39%
|
657,511
|
$29,082,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
623,640
|
$27,583,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.35%
|
579,412
|
$25,629,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.34%
|
560,928
|
$24,810,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.34%
|
559,956
|
$24,767,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.31%
|
511,975
|
$22,645,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.3%
|
504,488
|
$22,313,000 | — | 30 Sep 2022 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.3%
|
500,890
|
$22,154,000 | — | 30 Sep 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.27%
|
452,760
|
$20,026,000 | — | 30 Sep 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.27%
|
451,351
|
$19,964,000 | — | 30 Sep 2022 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
437,176
|
$19,336,000 | — | 30 Sep 2022 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
0.26%
|
437,176
|
$15,983,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.26%
|
436,824
|
$19,320,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.25%
|
418,232
|
$18,499,000 | — | 30 Sep 2022 | |
| Redmile Group, LLC |
13F
|
Company |
0.24%
|
407,659
|
$18,031,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.24%
|
406,483
|
$17,979,000 | — | 30 Sep 2022 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.23%
|
387,908
|
$17,149,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.2%
|
339,284
|
$15,007,000 | — | 30 Sep 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.2%
|
324,842
|
$14,368,000 | — | 30 Sep 2022 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.19%
|
323,586
|
$14,312,000 | — | 30 Sep 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.19%
|
323,529
|
$15,116,000 | — | 30 Sep 2022 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
302,600
|
$13,384,000 | — | 30 Sep 2022 | |
| DOWLING & YAHNKE LLC |
13F
|
Company |
0.18%
|
302,571
|
$13,383,000 | — | 30 Sep 2022 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.18%
|
300,013
|
$13,269,000 | — | 30 Sep 2022 |
Institutional Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2022
As of 31 Dec 2022,
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) was held by
333 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
130,693,455 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, Tweedy, Browne Co LLC, and ARK Investment Management LLC.
This page lists
334
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
335
Q4 2022 holders
333
Holder diff
-2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.